Central laboratories are under more pressure than ever. Increasingly complex protocols, frequent amendments, and growing data demands require speed, agility, and uncompromising scientific integrity. At ICON Laboratories,...
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Centre of the pharmaverse
Patients’ role in their own health has evolved more in the past decade than in the previous six combined. Consequently, an all-encompassing digital era has opened unique opportunities for industry to engage with patients meaningfully, while also creating a modernised healthcare landscape which yields trust and cooperation. Read more in PharmaTimes' January 2019 article, Centre of the pharmaverse, featuring insights from ICON experts Kelly Franchetti and Caroline Forkin.
-
How Value-Based Healthcare Affects Medical Device Development
Read this MPO Magazine article written by ICON expert Vicki Anastasi on how value-based healthcare (VBHC) models are expected to transform the health sector, impacting every aspect from patient care to drug pricing, and how partnering with a CRO can help manufacturers to demonstrate clinical efficacy and cost impact of new devices.
-
Ten Developments to Watch Out For in Life Sciences
Read The Irish Times’ article featuring commentary from ICON’s Tom O’Leary on the top digital and technological developments in the life science industry, including mHealth, AI, robotic process automation, blockchain and virtual technologies.
-
Optimizing Study Design in Real-World Evidence Generation
An Applied Clinical Trials article written by ICON’s Rob Sambrook exploring the importance of specialist epidemiology knowledge, due to their specialised focus on pharmacoepidemiological study design, to ensure robust and reliable downstream study findings.
-
A Look at Cost Challenges of Precision Medicine & Rare Disease
Published by Pharmafocus, authored by Will Maier, Chief Scientific Officer, Head of Rare Disease Research, ICON Commercialization and Outcomes, this article explores the cost challenges presented by precision medicine in rare disease and the strategies that can be employed to overcome them.
-
An Icon" in Clinical Research"
An article published by MoneyShow featuring ICON, which discusses ICON's unmatched global reach and expertise in oncology and work with Pfizer. In addition, the article discusses the role of the CRO in overcoming challenges in clinical trials.
-
ACT NOW – Cancer Trials At The Leading Edge
A thought leadership article published by Scrip, authored by Martin Lachs, Olivier Saulin and Chris Learn, on how CROs can best support increasing demand for Adoptive Cellular Transfer (ACT) clinical trials, and what sites can expect and commit to when participating in ACT trials.
-
Icon non-executive chairman awarded RDS gold medal for outstanding leadership
An article published by The Irish Times featuring commentary from Ciarán Murray on his achievement of being awarded with the RDS gold medal for enterprise for his “outstanding professional and leadership skills”.
-
Ciarán Murray – an Icon of leadership in pharma sector
An article published by The Irish Times featuring commentary from Ciarn Murray on the growth of ICON and his career journey to achieve the RDS Gold Medal for Industry.
-
Key Considerations for Disease Modifying Parkinson's Disease Trials
A thought leadership article by Peter Schueler and Haichen Yang on the key considerations for disease modifying parkinson's disease trials. This article is featured in Pharmaceutical Market Europe (PME).
